PRODUCTS
SERVICES
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
1.83
19 yrs 10 m
1%
7,125.28 Crs
1% on or before 1M, Nil after 1M
Large Growth
7.75
SIP 100 & Lumpsum 5000
S&P BSE HEALTH CARE - TRI
Sailesh Raj Bhan
Investors understand that their principal will be at very high risk